In Other News

• Fujifilm to Seek Approval for Anti-Influenza Drug to Treat COVID-19 Patients After Positive Phase 3 Trial Results

• Virus-Fighting Enzymes in Bacteria Could Lead to Development of Highly Effective Antiviral Drugs Against COVID-19

• Global COVID-19 Test Kits Market to Surpass USD 13 Billion by 2026

• GK Pharmaceuticals Accu-Right SARS-CoV-2 RT-PCR Kit Granted FDA Emergency Use Authorization

• New Patented Technology Determines Who Should Receive COVID-19 Vaccine First by Tracing Coronavirus “Super Distributors”

• New Study Finds Natural and Vaccine-Induced Immunity Will Shape Future Trajectory of Coronavirus Pandemic

• COVID-19 Study Finds High Rates of Unexplained Strokes and Delayed Recognition of Symptoms

• World's First Patient-Controlled Nasopharyngeal Swab Robot for COVID-19 Testing Reduces Risk of Exposure to SARS-CoV-2

• Druggable Pocket Discovered In SARS-CoV-2 Spike Protein Could Stop Coronavirus in Its Tracks

• New Assay That Mimics How SARS-CoV-2 Infects Cells Could Speed Up Discovery of COVID-19 Treatments

• AI-Based Digital Biomarker Could Assist in Early Intervention in High-Risk COVID-19 Patients

• Common Allergy Nasal Spray Medication Shows Potent Efficacy Against SARS-CoV-2

• Experimental Cancer Drug Inhibits SARS-CoV-2 Virus from Infecting Cells and Replicating

• Dual Bronchodilator and Anti-Inflammatory COPD Drug Offers Potential for COVID-19 Treatment

• Ortho Awarded BARDA Contract to Accelerate Development of SARS-CoV-2 Antigen Test

• Menarini Diagnostics Launches New SARS-CoV-2 Antigen Test That Also Measures Viral Load

• Experimental Drug Blocks SARS-CoV-2 from Entering Lung Cells

• Roche’s Actemra for Rheumatoid Arthritis Reduces Need for Mechanical Ventilation in Hospitalized COVID-19 Patients

• Potential New Drug Could Reduce Cellular Stress from SARS-CoV-2 Infection in COVID-19 Patients

• Snibe Diagnostic’s Maglumi 2019-nCoV IgM/IgG Test Granted FDA Emergency Use Authorization

• Rapid 90-Minute COVID-19 Test Shows High Accuracy in New Study

• Roche Launches New Quantitative Antibody Test to Measure SARS-CoV-2 Antibodies

• Abbott Reissued FDA Emergency Use Authorization for ID Now COVID-19 Test